Mobidiag develops and sells fast and accurate molecular diagnostic assays for the diagnosis of pathogenic microbes causing severe infections. The assays exploit Mobidiag’s Prove-it™ technology based on PCR amplification followed by specific target identification on microarray. Prove-it™ assays provide:
- accurate & reliable pathogen identification
- early diagnosis
- ease-of-use
Prove-itTM Products for In Vitro Diagnostics
Prove-it™ Sepsis (CE-IVD) provides accurate identification of bacteria and fungi present in positive blood culture in only 3,5 hours. Identifying over 60 bacterial and 13 fungal pathogens, and mecA gene marker 1 – 3 days earlier than the current sepsis diagnostics, Prove-it™ Sepsis enables early administration of effective antimicrobial treatment.
Prove-it™ Herpes (CE-IVD) is a two-hour assay identifying seven human herpesviruses in a single test. The assay is designed for rapid diagnostics of severe central nervous system infections.
Prove-itTM Platforms and Systems
Prove-it™ assays are available on two different platforms: Prove-it™ TubeArray and Prove-it™ StripArray. Mobidiag offers two solutions for the detection and analysis of the microarrays:Prove-it™TubeArray System and Prove-it™StripArray System. Both systems include the Prove-it™ Advisor software for fully automatic interpretation of the assay results.